コメント (10)
トラックバックは利用できません。
Concomitant Diflucan and warfarin requires intense INR monitoring due to increased bleeding risk.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Therapeutic success relies heavily on host immune status and source control.
Diflucan should be avoided in patients with known hypersensitivity to other azoles.
“Fluconazole-refractory” candidiasis is a specific clinical entity in advanced AIDS.
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
Therapeutic drug monitoring is not routinely required but can be useful in specific scenarios.
Protein binding is relatively low (~12), contributing to good tissue distribution.
Diflucan loading doses are used to achieve therapeutic levels rapidly in serious infections.
Concomitant Diflucan and warfarin requires intense INR monitoring due to increased bleeding risk.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Therapeutic success relies heavily on host immune status and source control.
Diflucan should be avoided in patients with known hypersensitivity to other azoles.
“Fluconazole-refractory” candidiasis is a specific clinical entity in advanced AIDS.
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Therapeutic drug monitoring is not routinely required but can be useful in specific scenarios.
Protein binding is relatively low (~12), contributing to good tissue distribution.
Diflucan loading doses are used to achieve therapeutic levels rapidly in serious infections.